New drug dotinurad takes on febuxostat in battle for heart health
NCT ID NCT06834230
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether dotinurad is better than febuxostat at improving blood vessel stiffness in 360 adults with high uric acid and high blood pressure. Participants will take one of the two drugs for 24 weeks. The goal is to see which drug better controls uric acid and supports heart health.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Saga University
RECRUITINGSaga, Saga-ken, 840-8502, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Squeeze away hypertension? handgrip device put to the test
- Blood pressure cuffs and health classes: a new approach to close a heart health gap
- AI tailors lifestyle tips to tackle high blood pressure
- Could a simple clinic Check-In change catch hidden high blood pressure and diabetes?
- Home visits may boost heart health for pregnant women in nigeria
- Six days of salty eating could reshape your taste buds